1. Home
  2. Analysis
  3. Atrovent
  4. Abelcet

Atrovent and Abelcet drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Atrovent and Abelcet. Common interactions include pneumonia among females and haemoglobin decreased among males.

The phase IV clinical study analyzes what interactions people who take Atrovent and Abelcet have. It is created by eHealthMe based on reports of 12 people who take Atrovent and Abelcet from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Mar, 18, 2023

12 people who take Atrovent and Abelcet together, and have interactions are studied.

What is Atrovent?

Atrovent has active ingredients of ipratropium bromide. It is often used in chronic obstructive pulmonary disease. eHealthMe is studying from 29,808 Atrovent users for its effectiveness, alternative drugs and more.

What is Abelcet?

Abelcet has active ingredients of amphotericin b. eHealthMe is studying from 828 Abelcet users for its effectiveness, alternative drugs and more.

Number of Atrovent and Abelcet reports submitted per year:

Atrovent and Abelcet drug interactions.

Common Atrovent and Abelcet drug interactions by gender *:

female:

  1. Pneumonia
  2. Respiratory failure
  3. Bronchospasm
  4. Central nervous system lesion
  5. Convulsions
  6. Dyspnoea
  7. Epstein-barr virus infection
  8. Hypertension
  9. Leukaemia recurrent
  10. Lung infiltration

male:

  1. Haemoglobin decreased
  2. Sepsis
  3. Oedema peripheral
  4. Platelet count decreased
  5. Pleural effusion
  6. Renal failure
  7. Skin nodule
  8. Ventricular tachycardia
  9. White blood cell count increased
  10. Antibody test positive

Common Atrovent and Abelcet drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Convulsions

30-39:

  1. Pleural effusion
  2. Pneumonia
  3. Respiratory failure

40-49:

  1. Activated partial thromboplastin time prolonged
  2. Blood urea increased
  3. Faecal occult blood positive
  4. Haematocrit decreased
  5. Haemoglobin decreased
  6. Platelet count decreased
  7. White blood cell count increased
  8. Bacterial infection
  9. Blood creatine increased
  10. Blood creatinine increased

50-59:

  1. Central nervous system lesion
  2. Epstein-barr virus infection
  3. Leukaemia recurrent
  4. Meningitis
  5. Pneumonia
  6. Pyrexia
  7. Rash
  8. Respiratory failure
  9. Sepsis

60+:

  1. Depressed level of consciousness
  2. Fluid overload
  3. Ventricular tachycardia
  4. Antibody test positive
  5. Blood bilirubin increased
  6. Blood pressure increased
  7. Blood pressure systolic decreased
  8. Bronchospasm
  9. Candidiasis
  10. Chills

Common conditions people have *:

  1. Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 2 people, 16.67%
  2. Sepsis (a severe blood infection that can lead to organ failure and death): 2 people, 16.67%
  3. Headache (pain in head): 1 person, 8.33%
  4. Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 1 person, 8.33%
  5. Bone Marrow Conditioning Regimen: 1 person, 8.33%
  6. Cryptococcosis (potentially fatal fungal disease): 1 person, 8.33%
  7. Eye Disorder: 1 person, 8.33%
  8. Fever: 1 person, 8.33%
  9. Gastric Disorder (disease of stomach): 1 person, 8.33%
  10. Venoocclusive Disease (small veins in the liver are obstructed): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Atrovent and Abelcet?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Atrovent and Abelcet:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Atrovent side effects:

Browse all side effects of Atrovent:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Abelcet side effects:

Browse all side effects of Abelcet:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Atrovent interactions:

Browse all interactions between Atrovent and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on ipratropium bromide and amphotericin b (the active ingredients of Atrovent and Abelcet, respectively), and Atrovent and Abelcet (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Atrovent and Abelcet.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2023 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.